SELL at $720. Base present value is $373.27 per ordinary share. The $33bn backlog supports growth, but capacity, contract funding and sustained margins must justify an already demanding price.
| Metric | Value |
|---|---|
| Bear | 115.87 |
| Base | 373.27 |
| Bull | 835.43 |
| Scenario | Probability | Present value | vs $720.00 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 25% | $115.87 | −84% | Weaker conversion, cost pressure and heavier funding | 2036 revenue $12.7bn; terminal growth 2.0% |
| Base | 50% | $373.27 | −48% | High-teens initial growth with measured margin expansion | 2036 revenue $20.6bn; terminal growth 2.5% |
| Bull | 25% | $835.43 | +16% | Strong delivery growth, superior margins and productive investment | 2036 revenue $25.9bn; terminal growth 3.0% |
| Subjective 25/50/25 weights; not statistical probabilities or guaranteed outcomes. | |||||
| Signpost | Now (Q3 2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| Deliveries | 2027 base revenue $10.738bn | Capacity converts orders into accepted output | Schedules slip or costs rise | 2027 quarters |
| Margins | Base initial 10.6% | Improvement after one-offs | Adjusted gains hide recurring pressure | Next results |
| Cash collections | Receivables and assets $4.933bn | Customer cash arrives on schedule | More funding tied up in receivables | Next quarters |
| IMOD agreement | Compensation amount undisclosed | Recognized benefit and actual cash | Headline without measurable collection | Future disclosure |
| Claims and ownership | Dated benefit and option proxies | Updated detailed roll-forwards | Unreconciled claims or dilution | Next annual filing |
Track cash economics and per-share claims alongside headline backlog. The model assumes growth; the valuation dispute is about how much durable cash that growth produces.
Our call is SELL at the retained November 17, 2026 quote of $720 per ordinary share, observed at 4:36:47 p.m. Eastern. Our main backlog-to-cash model estimates present fair value of $373.27. Conditional bear and bull scenarios produce $115.87 and $835.43. This is a valuation judgment about the price paid for future shareholder cash, not a claim that Elbit’s business is deteriorating. The base includes rapid growth, improving margins and a continuing flow of new contracts. The bull can support the current quote, but requires substantially better execution and economics together.
Elbit’s $33 billion September backlog, its broad technology portfolio and stronger international defense demand provide a credible foundation for growth. The difficult question is how much of that opportunity becomes cash after capacity expansion, contract costs, customer payment timing, taxes and existing claims. Backlog is neither revenue already earned nor cash already collected. A fixed-price contract can be valuable and still require more inventory, engineering and working capital than investors initially expect. A high stock price magnifies the consequence of even moderate disappointments.
The independent current-earnings check produces $323.40–$461.39 per share, using normalized operating earnings and a premium to observed large defense-prime multiples. It supports the direction of the valuation concern without independently proving the main model’s precise assumptions. The methods are kept separate. The DCF credits a long period of growth and operating improvement, while the cross-check asks what a generous capitalization of current normalized earnings would imply. We do not average them into a supposedly exact target.
The base annualized owner return through December 2031 is approximately negative 4.7%, including modeled distributions, versus an 11% required return. That dated return differs from the immediate gap between the quote and present value. The bull return is approximately 11.2%, just above the hurdle. Our conviction is 3 out of 5: the valuation gap is large, but defense demand, capacity utilization and sustained margins could be materially stronger than the central assumptions. A SELL rating does not imply a certain short-term decline or an instruction to short the shares.
| Metric | Value |
|---|---|
| Quote | 720.00 |
| Bear | 115.87 |
| Base | 373.27 |
| Bull | 835.43 |
Third-quarter revenue was $2.252 billion, up 17.2% from $1.922 billion in the comparable 2025 quarter. Gross profit reached $570.6 million, and reported gross margin increased to 25.3% from 24.9%. GAAP operating income rose to $232.5 million, or 10.3% of sales, compared with $171.4 million and 8.9%. Net income attributable to Elbit shareholders was $177.9 million, with diluted EPS of $3.70. The company’s adjusted diluted EPS was $4.36. These figures describe a strong reported quarter, but the adjusted and GAAP definitions must not be mixed.
Research and development expense was $145.6 million, selling and marketing expense was $103.2 million, and general and administrative expense was $99.2 million. The company recognized approximately $20 million of research incentives across cost of sales and R&D. It also recorded a $9.874 million operating gain from a subsidiary sale. Those benefits help explain reported profitability and should not automatically be capitalized as recurring annual earnings. Removing both benefits and adding back only $7.9 million of acquired-intangible amortization gives a normalized quarterly operating reference of about $210.5 million.
We retain employee compensation and special operating costs in that normalized reference. The company’s adjusted presentation excludes additional items, including stock compensation, but employee services remain an economic cost to owners. The approximately $27 million pension-termination expense appears below operating income. It affects reported net income, but subtracting it again from operating profit would put the same item in the wrong place twice. Net financing expense fell to $16.3 million from $34.5 million, partly reflecting lower average debt balances.
The reported effective tax rate was 11.6%, versus 8.2% a year earlier, with global minimum-tax rules contributing to the change. Our base uses an 18% normalized operating tax rate rather than extending one quarter’s unusually low rate indefinitely. Affiliate income and investment-related items are separated from operating cash generation and considered through the investment bridge. These choices make the model less dependent on non-operating gains or a temporarily favorable tax mix.
| Metric | Value |
|---|---|
| 2025 revenue | 1,921.61 |
| 2026 revenue | 2,252.06 |
| Metric | Value |
|---|---|
| Reported EBIT | 232.49 |
| Normalized EBIT | 210.51 |
| Parent net income | 177.93 |
Elbit supplies defense and security systems across aerospace, command and communications, intelligence and electronic warfare, land systems and its United States operations. Products often form part of long procurement programs with qualification, integration and support requirements. Those relationships can produce recurring work and barriers to entry. They also create obligations that are more complex than selling a standardized item from inventory. Cost estimates, engineering changes, acceptance milestones and supplier reliability affect the final cash margin.
External third-quarter revenue included $737.9 million from Land, $403.3 million from ISTAR and electronic warfare, $260.7 million from C4I and Cyber, $427.3 million from Aerospace and $422.9 million from the U.S. segment. Total segment revenue of approximately $2.424 billion includes $171.6 million of internal transactions that are eliminated on consolidation. Our cash model uses the consolidated $2.252 billion external-customer base. Adding all segment totals without eliminating internal sales would overstate the economic business.
Strong land and electronic-warfare demand does not mean every product line has the same outlook. Aerospace commentary includes weaker precision-guided-munition sales in Asia-Pacific, while other areas benefit from greater demand for protection, sensing, communications and munitions. Program and geography mix can change profitability even when total revenue continues rising. The company’s disclosed segment growth rates use its segment presentation; they are not interchangeable with growth calculated from external revenue alone.
Israel represented $845.4 million, or 37.5%, of quarterly consolidated revenue. Europe contributed $556.9 million, North America $456.0 million and Asia-Pacific $289.4 million. International diversification broadens the customer base but introduces different procurement rules, export approvals, currencies, local-content requirements and delivery schedules. Much reporting is in U.S. dollars, while some labor and production costs arise in other currencies. A favorable demand environment therefore does not remove exchange-rate or execution risk.
| Metric | Value |
|---|---|
| Land | 737.90 |
| ISTAR / EW | 403.30 |
| C4I / Cyber | 260.70 |
September order backlog was $33.0 billion, compared with $32.0 billion at June 30. Approximately 74% was attributable to customers outside Israel. Management expects about 35% to be performed during the remainder of 2026 and in 2027. That schedule represents roughly $11.55 billion of backlog deliveries across the stated period. It does not mean 35% will all be recognized in 2027, and it does not include every future quick-turn order that could contribute to revenue.
The company describes backlog as firm commitments under its reporting policy. Contracts can nevertheless change, face funding or acceptance delays, or be terminated under their terms. Backlog therefore supports visibility but is not a guaranteed margin or a liquidation asset worth its face amount. The company must still deliver the products, incur the related costs and satisfy the customer. A canceled or delayed contract can leave inventory and capacity costs behind even when some contractual recovery is available.
Our starting 2026 revenue assumption is $9.1 billion. After the reported $6.728 billion for nine months, that implies $2.372 billion in the fourth quarter. We subtract that assumed delivery from the $11.55 billion scheduled amount to estimate approximately $9.178 billion of opening backlog delivery in 2027. We add an explicit $3 billion fourth-quarter order assumption to derive opening 2027 backlog of $33.628 billion. These are author assumptions, not additional management guidance.
The base then combines opening-backlog conversion with quick-turn delivery from new orders, constrained by production capacity. Initial 2027 orders are assumed at $14.5 billion, while capacity supports $10.738 billion of revenue. Approximately $9.178 billion comes from the opening backlog and $1.560 billion from newer work. Ending backlog rises to about $37.390 billion because orders exceed deliveries. That modeled accumulation is a consequence of the order assumptions, not a claim that those future contracts have already been awarded.
| Metric | Value |
|---|---|
| Opening backlog work | 9,177.96 |
| Newer work | 1,560.04 |
| Total revenue | 10,738.00 |
Management expects high-teens revenue growth in 2027 and continued margin expansion, without supplying an exact margin forecast. Our base uses 18% growth over the assumed full-year 2026 revenue, consistent with that broad growth commentary. Subsequent capacity growth fades from 15% toward 3% as the explicit forecast matures. Orders and delivery conversion are modeled separately, so a strong order book cannot create revenue faster than the capacity assumption allows.
Most contracts are fixed price. Higher labor, components, rework or logistics costs can therefore fall on Elbit when the contract does not provide adequate recovery. The annual report’s $186.3 million contract-loss provision is dated December 2025, not a new Q3 2026 charge. It provides evidence that execution risk can become an accounting and cash obligation. We do not assume each new award earns the same margin, nor do we treat backlog growth as proof that cost estimates are conservative.
Nine-month capital spending, net of investment and evacuation grants, was $226.2 million, compared with $128.4 million a year earlier. Depreciation and amortization totaled $142.3 million, including $23.0 million of acquired-intangible amortization. The Ramat Beka munitions facility is part of the capacity ramp, with production and relocation activities requiring investment and execution. We do not assume the full project is complete or that every dollar of new equipment immediately reaches mature utilization.
The base operating margin begins at 10.6% in 2027 and rises gradually to 12.5% in 2036, after economic employee compensation. Physical capital spending declines from 3.5% to 2.5% of revenue as capacity matures, while ordinary depreciation is 1.9%. In 2027, $375.8 million of capital spending exceeds $204.0 million of ordinary depreciation. The resulting cash burden remains visible even as revenue and accounting profit grow. Terminal reinvestment is linked to an 18% incremental return on capital, so perpetual growth does not arrive without a capital cost.
| Metric | Value |
|---|---|
| 2027 capex | 375.83 |
| Ordinary depreciation | 204.02 |
| Working-capital increase | 125.66 |
Nine-month operating cash flow was $862.5 million, up from $461.0 million in the prior-year period. The cash statement includes a $1.143 billion benefit from increases in customer advances and a $433.9 million contribution from operating payables. These inflows offset $1.128 billion invested in receivables and prepayments and $230.8 million in inventory. Cash generation is therefore partly a contract-timing result, not simply reported earnings converted at a stable percentage.
At September 30, current and long-term customer advances totaled $4.760 billion. Current and long-term receivables and contract assets totaled approximately $4.933 billion, with another $571.0 million of other receivables and prepaid expenses and $3.357 billion of inventory. Our selected gross operating working-capital proxy subtracts trade payables and both current and long-term advances from those operating assets, producing approximately $2.400 billion. That is a modeled definition, not a company-reported subtotal.
We then subtract an operating-accrual proxy of $1.783 billion, derived from $1.818 billion of other payables after removing the dated $35.273 million current pension proxy that is handled separately in the claim bridge. The resulting opening net operating working capital is $616.746 million. The current release does not provide a complete breakdown of other payables. Annual notes show a mixture of payroll, vacation, warranty, royalties, taxes, contract-loss provisions, derivatives and other items. Treating the selected balance as scalable operating funding is an approximation and is tested explicitly.
The forecast charges changes in net working capital as revenue grows. Gross selected working capital starts at 26.5% of revenue and rises to 28%, while the operating-accrual ratio remains approximately 19.6%. Initial net funding is about 6.9% of sales, increasing toward 8.4%. We do not deduct all customer advances again as financial debt after already including delivery costs and the working-capital movement. Removing all forecast scaling from the accrual funding proxy lowers present value to approximately $343.81. Adding five percentage points to the net funding requirement lowers it to about $357.41.
| Metric | Value |
|---|---|
| Advance benefit | 1,142.82 |
| Receivable cash use | 1,127.88 |
| Inventory cash use | 230.79 |
| Metric | Value |
|---|---|
| Base | 373.27 |
| No accrual scaling | 343.81 |
| Extra 5pt funding | 357.41 |
The November agreement with the Israeli Ministry of Defense provides for compensation related to delayed payments since October 2023, subject to stated criteria. The earnings release does not quantify a cash settlement amount or establish that all overdue receivables have been collected. We assign no invented windfall. The agreement may improve economics when its terms translate into recognized income and cash, but it does not eliminate ordinary customer payment risk or future funding needs.
New announcements illustrate the duration of procurement relationships. The company reported a $260 million European rocket-system award with a five-year delivery period and a $170 million Israeli training-center award over fifteen years. These figures are contract values over the specified schedules, not immediate quarterly revenue. They may contribute to future backlog and deliveries according to the company’s accounting and contract terms. A long contract can provide visibility while spreading its profit and cash contribution over many years.
The company continues to describe risks from hostilities, personnel availability, supply chains, logistics, facilities and restrictions on international trade or exports. We do not assume those issues are resolved. Demand can rise during security crises while operating risk and cost also rise. Customer budgets and political decisions may support or delay specific programs independently of underlying military need. Export licenses, local approvals and customer acceptance remain relevant even after a headline contract award.
These uncertainties map to different model inputs. Lower orders or cancellations reduce future backlog; slower approvals or production reduce conversion; cost overruns reduce margins; delayed customer payments increase working capital; and disruptions can raise the cash reserve or required return. Our scenarios combine several of these effects rather than hiding them in a single generic risk discount. Severe events could produce outcomes below the modeled bear, which assumes the business continues operating.
| Metric | Value |
|---|---|
| European rocket systems | 260.00 |
| IMOD training center | 170.00 |
Cash of $174.0 million plus short-term deposits of $1.055 billion gives $1.229 billion of reported September liquidity. Cash alone declined while deposits increased, so focusing on the cash line by itself would misread the change. We retain $600 million as an author operating reserve, leaving $629.4 million in the base bridge. This reserve is a valuation assumption, not a reported restriction or a promise that the remainder can immediately be paid out.
Reported bank loans and notes total $327.0 million at carrying value across current and long-term balances. We use that amount as a financial-debt proxy. Investments in affiliated companies and other companies total $141.4 million; the base applies a 10% realization allowance and credits $127.3 million. The separate $180.1 million long-term deposits and other receivables line is mixed, so it is not all added as excess cash. Affiliate earnings are excluded from the operating forecast to avoid crediting those assets twice.
The legacy employee-benefit bridge starts with September long-term liabilities of $500.8 million and offsets the dedicated severance fund of $228.8 million. It adds the $35.273 million current pension liability reported at December 2025 as a clearly dated proxy, producing a $307.2 million reserve. The fund is dedicated to employee obligations, not freely distributable cash. The annual report’s separate defined-benefit deficit, other postretirement and executive-compensation figures are context, not extra deductions on top of the aggregate bridge. The September release does not provide a complete plan-by-plan roll-forward, so possible classification and settlement changes remain uncertain.
We do not separately deduct a future legacy pension-funding schedule for the same reserve. Current service costs stay in operating margins. The dated $13.035 million contingent purchase consideration is reserved separately, while the entire other-long-term-liability balance is not mislabeled financial debt. Operating leases remain within the operating expense and cash model, without a lease-debt deduction or a separate lease-depreciation addback. The completed October 20 ISE acquisition has an undisclosed price that the issuer calls not material; we invent neither its price nor a synergy benefit. A separate hypothetical $100 million additional outflow reduces base value to about $371.24.
| Bridge component | USD millions |
|---|---|
| excess cash | 629.441 |
| investments | 127.260 |
| debt | −326.984 |
| employee legacy | −307.211 |
| contingent purchase | −13.035 |
| minority | −0.387 |
| existing award expense credit | 23.828 |
The denominator begins with the issuer’s 46.858 million basic weighted-average shares for the third quarter. It is not a verified November spot register. The diluted quarterly average was 48.128 million. The detailed annual report disclosed 46.442 million ordinary shares at December 2025. These counts serve different purposes and dates; none should be silently relabeled as the current fully diluted ownership base. Elbit’s Nasdaq security is an ordinary share, so no ADS conversion is applied.
The last retained detailed option schedule is also dated December 2025: 2.408 million options outstanding at a weighted exercise price of $208.99. We allocate their modeled intrinsic claim against common value using a simplified cashless approach. We do not both add exercise proceeds and deduct the same full option claim. The weighted strike is an approximation because the individual tranches have different prices and dates. Applying the schedule at a future valuation horizon is an economic allocation proxy, not a claim that every older contract remains outstanding until that horizon.
Some 2026 exercises or settlements may already overlap the newer weighted basic count. The current quarter does not supply a complete award roll-forward to resolve that overlap. A 2% increase in the basic-share proxy reduces base value to approximately $366.30, and the limitations are carried into the decision. The model does not assume the difference between basic and diluted quarterly averages is a complete inventory of all current claims. Nor does it grant hypothetical buybacks without the associated cash cost.
Future economic stock compensation remains in margins. To reduce double counting for existing options already allocated separately, we estimate a limited remaining-expense credit: December unrecognized compensation of $56.141 million less nine-month 2026 expense of $24.322 million, then tax-effected and discounted. The base credit is about $23.8 million in present value. This is not a verified September unrecognized-expense balance: new grants, post-quarter recognition and award timing can differ. Removing the credit entirely changes base value by only about $0.48 per share. New future awards receive no separate expense credit.
| Metric | Value |
|---|---|
| Base value | 373.27 |
| Basic shares +2% | 366.30 |
| No expense credit | 372.79 |
The main model forecasts ten years of orders, backlog conversion, capacity, operating margin, taxes, physical investment and contract working capital. Initial revenue is constrained by capacity rather than obtained by multiplying all backlog by an arbitrary valuation multiple. Base revenue reaches approximately $15.519 billion in 2031 and $20.566 billion in 2036. Ending modeled backlog continues rising because the assumed order path exceeds deliveries; investors should not confuse that conditional output with signed future awards.
In 2027, operating income of $1.138 billion is taxed at 18%, leaving $933.3 million of net operating profit after tax. Adding ordinary depreciation of $204.0 million, subtracting $375.8 million of capital spending and $125.7 million of additional working capital produces $635.9 million of free cash flow to the firm. The same calculation yields approximately $1.127 billion in 2031 and $1.910 billion in 2036. Interest is excluded from this enterprise cash flow and considered separately when estimating owner distributions.
The base discounts operating cash at 9.5%. Terminal growth is 2.5%, with reinvestment required at an 18% incremental return on capital. Terminal value contributes about 59.8% of operating enterprise value, an important limitation: much of the estimate depends on economics beyond the explicit forecast. The resulting operating enterprise value is $17.754 billion. The net financial-asset and claim bridge adds about $133 million before the option allocation and per-share calculation.
The valuation date is November 17. Only 44 days of normalized remaining-2026 cash are added, rather than a full quarter whose early portion has already elapsed. September balance-sheet figures remain dated proxies because a complete November balance sheet is unavailable. Future price estimates are ex-distribution; modeled equivalent distributions are counted separately in the owner-return calculation. The company’s announced $1 dividend, payable January 4, 2027 to the December 21 record date, is not added again on top of a total modeled payout stream that already represents owner cash.
| Metric | Value |
|---|---|
| 2027 FCFF | 635.88 |
| 2031 FCFF | 1,126.77 |
| 2036 FCFF | 1,910.18 |
| Year | Revenue | EBIT margin | Capex | Change in NWC | FCFF |
|---|---|---|---|---|---|
| 2027 | 10,738.0 | 10.6% | 375.8 | 125.7 | 635.9 |
| 2028 | 11,970.8 | 10.8% | 405.7 | 130.0 | 753.0 |
| 2029 | 13,185.6 | 11.0% | 432.2 | 137.9 | 872.2 |
| 2030 | 14,372.3 | 11.2% | 455.1 | 144.7 | 997.1 |
| 2031 | 15,519.2 | 11.4% | 474.2 | 150.3 | 1,126.8 |
| 2032 | 16,627.3 | 11.7% | 489.6 | 93.1 | 1,322.4 |
| 2033 | 17,693.9 | 11.9% | 501.3 | 89.6 | 1,466.9 |
| 2034 | 18,713.9 | 12.1% | 509.4 | 85.7 | 1,613.8 |
| 2035 | 19,680.3 | 12.3% | 513.9 | 81.2 | 1,762.0 |
| 2036 | 20,566.1 | 12.5% | 514.2 | 74.4 | 1,910.2 |
The independent check starts with current operating earnings rather than the DCF’s future backlog and capacity path. Reported trailing operating income is adjusted to remove the quarterly research incentive and subsidiary-sale gain while adding acquired-intangible amortization. Stock compensation remains an economic expense. The resulting normalized trailing operating reference is approximately $849.8 million. This creates a separate starting point from the long-run forecast, although the same financial claims must still be respected.
Retrieved November 17 market statistics show enterprise-value-to-operating-earnings ratios around 17.52 times for Lockheed Martin, 15.86 times for Northrop Grumman and 18.28 times for L3Harris. We select an 18–26 times range for Elbit, explicitly allowing a substantial premium for its stronger growth opportunity. Those multiples are author judgments informed by current market context, not a reported market consensus or a mechanical average. The resulting present-value range is $323.40–$461.39 per share after the same bridge and ownership treatment.
The companies differ in geography, program mix, pension treatment, taxes, leases and contract economics. This comparison approximates those differences rather than proving identical accounting normalization. A growth premium does not make the businesses interchangeable. The check is useful because even its generous upper multiple remains materially below the $720 quote. It would become less persuasive if Elbit’s normalized earnings rose rapidly enough that current earnings ceased to represent a useful starting point.
The retrieved Street target average is $838.92 from six analysts, but the target table carries an October 16 update date. We identify it as dated context, not as a fresh reaction to this release. Our November 2027 base price is $405.56 before distributions, while our present value is $373.27. Street targets, a future modeled price and a present DCF value have different timing and assumptions. Displaying them together should clarify disagreement, not imply they are equivalent measures.
| Metric | Value |
|---|---|
| 18× normalized EBIT | 323.40 |
| 22× normalized EBIT | 392.40 |
| 26× normalized EBIT | 461.39 |
The bear combines weaker conversion and capacity growth with lower operating margins, heavier reinvestment and a higher discount rate. It still assumes continuing operations, so its $115.87 present value is not an assured downside floor. The base includes high-teens initial growth and gradual margin expansion. The bull requires stronger deliveries, better sustained margins and productive investment, together with a lower required operating return. Its $835.43 present value and approximately 11.2% owner return show what must go well for the current price to be justified.
Subjective probabilities are 25% bear, 50% base and 25% bull. They organize uncertainty rather than represent statistically estimated odds. The weighted present value is shown separately from the central case. Operating sensitivities change conversion and margin, while rate sensitivities change discount and terminal-growth assumptions. Dated balance and ownership proxies receive separate tests. None of these exercises guarantees that extreme geopolitical, contract or customer-credit events fit inside the displayed range.
The reverse model holds the base revenue, investment, tax and claim assumptions fixed and solves for the operating-margin shift needed to support $720. It requires approximately 10.56 percentage points above the base margin path: about 21.16% initially, rising to about 23.06% at maturity, compared with 10.6% and 12.5% in the base. That is a demanding result for this operating structure. It does not mean every investor literally forecasts those margins; a faster revenue path, lower required return or different capital assumptions could also explain the price.
The next evidence to watch is whether 2027 growth arrives with normalized margin improvement, cash collection and productive capacity use. Receivable movements and actual cash under the IMOD agreement matter more than an unquantified headline benefit. New order quality, delivery milestones and contract-loss provisions test backlog economics. Updated pension and award disclosures can refine the bridge. The conclusion improves if those facts support stronger per-share cash without excessive investment; it weakens if revenue growth requires more funding or produces less margin than expected.
| Metric | Value |
|---|---|
| Base initial | 10.60 |
| Price-implied initial | 21.16 |
| Base mature | 12.50 |
| Metric | Value |
|---|---|
| 8.5% / 2.0% | 427.34 |
| 8.5% / 2.5% | 441.62 |
| 8.5% / 3.0% | 458.40 |
| 9.5% / 2.0% | 364.39 |
| 9.5% / 2.5% | 373.27 |
| 9.5% / 3.0% | 383.45 |
| 10.5% / 2.0% | 316.65 |
| 10.5% / 2.5% | 322.36 |
| 10.5% / 3.0% | 328.77 |
The current-period primary sources are Elbit’s November 17, 2026 earnings release, its detailed financial tables and the original issuer-distributed PR Newswire release. The wire timestamp is 2:54 a.m. Eastern Standard Time, equivalent to 1:54 a.m. Chicago time. The report covers the quarter ended September 30, 2026. The 2025 annual report supplies detailed contract, pension, compensation and liability notes where the shorter interim release does not provide a full roll-forward. Those annual figures remain explicitly dated proxies.
The October 20 issuer announcement establishes completion of the ISE acquisition and the company’s statement that the consideration is not material. It does not disclose a transaction price. The dated share quote is from Yahoo Finance, while the analyst-target table and defense-prime market ratios are from Stock Analysis. The exact quote time used is stated in the packet. Market fields can update on different schedules, so we avoid presenting the October target average as a newly revised consensus following these results.
The displayed tables show the key operating forecast, cash-flow bridge, claims, sensitivities and return distinctions. Growth, capacity, margins, reserves, realization allowances, discount rates and probability weights are Charged Alpha assumptions. They are not company promises. The model preserves economic compensation, treats customer advances through delivery economics and working capital, and discloses the remaining limits in the share, benefit and acquisition proxies. Estimates are rounded for readability, while calculations retain greater precision.
This analysis is a dated assessment of business economics and price. Stronger demand can coexist with an unattractive expected return when the market already anticipates exceptional performance. Conversely, the central model can be too cautious about sustained growth or margins. The independent check and the bull scenario remain visible because those alternatives matter. Readers should evaluate new evidence against the underlying drivers rather than treating one fair-value number as a permanent fact.
Primary references: Q3 issuer results; dated issuer wire; 2025 annual report and notes; ISE completion announcement. Market context: ESLT quote; dated analyst targets; Lockheed Martin ratios; Northrop Grumman ratios; L3Harris ratios.